| SLN#1 was first positive SLN (n = 86) | SLN#1 was not first positive SLN (n = 18) | P-value |
---|---|---|---|
Macrometastatic (> 2 mm) | 58 (67%) | 11 (61%) | 0.605 |
Micrometastatic (≤ 2 mm, but > 0.2 mm) | 21 (24%) | 3 (17%) | 0.759 |
Submicrometastatic (≤ 0.2 mm) | 7 (8%) | 4 (22%) | 0.095 |